Quick Links

Publications:

Coffee and the Risk of Atrial Fibrillation.

Authors: Shereif H Rezkalla|||Robert A Kloner

Journal: Cardiology research

Publication Type: Journal Article

Date: 2026

DOI: PMC13719655

ID: 42964423

Affiliations:

Affiliations

    Marshfield Clinic Research Institute, Sanford Health, Marshfield, WI, USA.|||Cardiovascular Research Institute, Huntington Medical Research Institutes, Pasadena, CA, USA.

Abstract

Most hospitals and cardiac rehabilitation facilities provide decaffeinated coffee to cardiac patients in place of regular coffee. Recent studies, however, suggest that coffee drinking may decrease the risk of developing cardiovascular diseases. Review of controlled studies shows that drinking regular coffee in moderation is safe. It may even lead to a decrease in atrial arrhythmias such as atrial fibrillation, and it is safe in patients with ventricular arrhythmias. This is particularly true in patients who drink coffee regularly and in moderation. Energy drinks, however, that contain large doses of caffeine may indeed be harmful and should be avoided. The policies of serving only decaffeinated coffee in hospitals and rehabilitation facilities should be revisited.


Reference List

    Higdon JV, Frei B. Coffee and health: a review of recent human research. Crit Rev Food Sci Nutr. 2006;46(2):101–123. doi: 10.1080/10408390500400009.|||Ding M, Bhupathiraju SN, Chen M, van Dam RM, Hu FB. Caffeinated and decaffeinated coffee consumption and risk of type 2 diabetes: a systematic review and a dose-response meta-analysis. Diabetes Care. 2014;37(2):569–586. doi: 10.2337/dc13-1203.|||Larsson SC, Orsini N. Coffee consumption and risk of stroke: a dose-response meta-analysis of prospective studies. Am J Epidemiol. 2011;174(9):993–1001. doi: 10.1093/aje/kwr226.|||Ding M, Bhupathiraju SN, Satija A, van Dam RM, Hu FB. Long-term coffee consumption and risk of cardiovascular disease: a systematic review and a dose-response meta-analysis of prospective cohort studies. Circulation. 2014;129(6):643–659. doi: 10.1161/CIRCULATIONAHA.113.005925.|||Crippa A, Discacciati A, Larsson SC, Wolk A, Orsini N. Coffee consumption and mortality from all causes, cardiovascular disease, and cancer: a dose-response meta-analysis. Am J Epidemiol. 2014;180(8):763–775. doi: 10.1093/aje/kwu194.|||Marcus GM, Rosenthal DG, Nah G, Vittinghoff E, Fang C, Ogomori K, Joyce S. et al. Acute effects of coffee consumption on health among ambulatory adults. N Engl J Med. 2023;388(12):1092–1100. doi: 10.1056/NEJMoa2204737.|||Wong CX, Cheung CC, Montenegro G, Oo HH, Pena IJ, Tang JJ, Tu SJ. et al. Caffeinated coffee consumption or abstinence to reduce atrial fibrillation: the DECAF RANDOMIZED CLINICAL TRial. JAMA. 2026;335(4):317–325. doi: 10.1001/jama.2025.21056.|||Kim EJ, Hoffmann TJ, Nah G, Vittinghoff E, Delling F, Marcus GM. Coffee consumption and incident tachyarrhythmias: reported behavior, mendelian randomization, and their interactions. JAMA Intern Med. 2021;181(9):1185–1193. doi: 10.1001/jamainternmed.2021.3616.|||Iten V, Herber E, Coslovsky M, Hennings E, Paladini RE, Reichlin T, Rodondi N. et al. Coffee consumption and adverse cardiovascular events in patients with atrial fibrillation. BMC Med. 2024;22(1):593. doi: 10.1186/s12916-024-03817-x.|||Bazal P, Gea A, Navarro AM, Salas-Salvado J, Corella D, Alonso-Gomez A, Fito M. et al. Caffeinated coffee consumption and risk of atrial fibrillation in two Spanish cohorts. Eur J Prev Cardiol. 2021;28(6):648–657. doi: 10.1177/2047487320909065.|||Yuan S, Larsson SC. No association between coffee consumption and risk of atrial fibrillation: A Mendelian randomization study. Nutr Metab Cardiovasc Dis. 2019;29(11):1185–1188. doi: 10.1016/j.numecd.2019.07.015.|||Bodar V, Chen J, Gaziano JM, Albert C, Djousse L. Coffee consumption and risk of atrial fibrillation in the Physicians' health study. J Am Heart Assoc. 2019;8(15):e011346. doi: 10.1161/JAHA.118.011346.|||Mostofsky E, Johansen MB, Lundbye-Christensen S, Tjonneland A, Mittleman MA, Overvad K. Risk of atrial fibrillation associated with coffee intake: Findings from the Danish Diet, Cancer, and Health study. Eur J Prev Cardiol. 2016;23(9):922–930. doi: 10.1177/2047487315624524.|||Larsson SC, Drca N, Jensen-Urstad M, Wolk A. Coffee consumption is not associated with increased risk of atrial fibrillation: results from two prospective cohorts and a meta-analysis. BMC Med. 2015;13:207. doi: 10.1186/s12916-015-0447-8.|||Mattioli AV, Farinetti A, Miloro C, Pedrazzi P, Mattioli G. Influence of coffee and caffeine consumption on atrial fibrillation in hypertensive patients. Nutr Metab Cardiovasc Dis. 2011;21(6):412–417. doi: 10.1016/j.numecd.2009.11.003.|||Caldeira D, Martins C, Alves LB, Pereira H, Ferreira JJ, Costa J. Caffeine does not increase the risk of atrial fibrillation: a systematic review and meta-analysis of observational studies. Heart. 2013;99(19):1383–1389. doi: 10.1136/heartjnl-2013-303950.|||Hamad AKS. Caffeine and Arrhythmias: A Critical Analysis of Cardiovascular Responses and Arrhythmia Susceptibility. J Saudi Heart Assoc. 2024;36(4):335–348. doi: 10.37616/2212-5043.1402.|||Chen S, Li J, Gao M, Li D, Shen R, Lyu L, Shen J. et al. Association of caffeine intake with all-cause and cardiovascular mortality in elderly patients with hypertension. Front Nutr. 2022;9:1023345. doi: 10.3389/fnut.2022.1023345.|||Varani K, Portaluppi F, Merighi S, Ongini E, Belardinelli L, Borea PA. Caffeine alters A2A adenosine receptors and their function in human platelets. Circulation. 1999;99(19):2499–2502. doi: 10.1161/01.cir.99.19.2499.|||Graboys TB, Blatt CM, Lown B. The effect of caffeine on ventricular ectopic activity in patients with malignant ventricular arrhythmia. Arch Intern Med. 1989;149(3):637–639.|||Myers MG, Harris L. High dose caffeine and ventricular arrhythmias. Can J Cardiol. 1990;6(3):95–98.|||Mukamal KJ, Alert M, Maclure M, Muller JE, Mittleman MA. Tea consumption and infarct-related ventricular arrhythmias: the determinants of myocardial infarction onset study. J Am Coll Nutr. 2006;25(6):472–479. doi: 10.1080/07315724.2006.10719561.|||Chelsky LB, Cutler JE, Griffith K, Kron J, McClelland JH, McAnulty JH. Caffeine and ventricular arrhythmias. An electrophysiological approach. JAMA. 1990;264(17):2236–2240.|||Wennmalm A, Wennmalm M. Coffee, catecholamines and cardiac arrhythmia. Clin Physiol. 1989;9(3):201–206. doi: 10.1111/j.1475-097x.1989.tb00972.x.|||Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS. et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction) Circulation. 2004;110(5):588–636. doi: 10.1161/01.CIR.0000134791.68010.FA.|||Marcus GM, Hu FB, van Dam RM, Cornelis MC, Dewland TA, Kang J, Larsson SC. et al. Caffeine and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2026;154(9):e345–e355. doi: 10.1161/CIR.0000000000001454.